Wenshen Xiaozheng Tang alleviates fibrosis in endometriosis by regulating differentiation and paracrine signaling of endometrium-derived mesenchymal stem cells

Datos Bibliográficos

ID14729348
AutoresZhenzhen Zhang (0000-0001-6195-0411, Nanjing University of Chinese Medicine, autor de correspondencia), Xue Zhou (0000-0002-9365-5887, Nanjing University of Chinese Medicine), Lu Xia (0000-0003-1859-9755, Nanjing University of Chinese Medicine), Nan Li (0009-0000-4562-451X, Nanjing University of Chinese Medicine), Shihan Xu (0009-0001-5001-9733, Nanjing University of Chinese Medicine), Xiaohong Dong (0009-0008-9157-8970, Nanjing University of Chinese Medicine), Li Zhu (0000-0003-0179-6496, Nanjing University of Chinese Medicine), Meihua Huang (Nanjing University of Chinese Medicine), Guiping Wan (0000-0001-6940-938X, Nanjing University of Chinese Medicine, autor de correspondencia)
Año2025
Volumen336
Páginas118724
Fecha de publicación2025-01-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaJournal of Ethnopharmacology (JOURNAL)
Identificadores de la revistaISSN: 0378-8741 • E-ISSN: 1872-7573
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2024.118724
PMID39181283
OpenAlexW4401799328
IdiomaEN
Referencias citadas36

WXT improved fibrosis in endometriosis by regulating differentiation and paracrine signaling of eMSCs. Thrombospondin 4, whose release from ectopic eMSCs is inhibited by WXT, may be a potential target for the treatment of endometriosis

Biology · Decoction · Endometriosis · Endometrium · Fibrosis · Mesenchymal stem cell · Paracrine signalling · Pathology · Receptor · Stem cell · Traditional medicine · Endometrial and Cervical Cancer Treatments · Endometriosis Research and Treatment · Medicine · Uterine Myomas and Treatments · Cancer Research · Cell Biology · Internal Medicine